RB loses final Nurofen appeal in High Court

It must pay the $6 million penalty for making misleading representations about its Nurofen Specific Pain products A final High Court appeal by Reckitt Benckiser against a penalty imposed for contravening the Australian Consumer Law has been rejected this week, Fairfax reports. The initial $1.7 million penalty handed down by the Full Court in April